Quick Answer
Cyclerion Therapeutics, Inc. reported Common Stock Shares Outstanding of 3.82 million shares for the year ending 2025.
- Cyclerion Therapeutics, Inc. showed an increase of +50.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Cyclerion Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: 3.82 million shares | Fiscal year 2024: 2.55 million shares | Fiscal year 2023: 2.47 million shares | Fiscal year 2022: 2.18 million shares | Fiscal year 2021: 43.41 million shares | Fiscal year 2020: 34.05 million shares | Fiscal year 2019: 27.60 million shares | Fiscal year 2018: 0 shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: